<Suppliers Price>

AG-13958

Names

[ CAS No. ]:
319460-94-1

[ Name ]:
AG-13958

[Synonym ]:
N-[2-Fluoro-5-({3-[(E)-2-(2-pyridinyl)vinyl]-1H-indazol-6-yl}amino)phenyl]-1,4-dimethyl-1H-pyrazole-5-carboxamide
2,5-dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylamino]-phenyl}-amide
1H-Pyrazole-5-carboxamide, N-[2-fluoro-5-[[3-[(E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-1,3-dimethyl-
6-[N-(3-((1,3-dimethyl-1H-pyrazol-5-yl)carboxamido)-4-fluoro-phenyl)amino]-3-(E)-[2-(pyridin-2-yl)ethenyl]-1H-indazole
N-[2-Fluoro-5-({3-[(E)-2-(2-pyridinyl)vinyl]-1H-indazol-6-yl}amino)phenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide
6-[methyl(phenylsulfonyl)amino]-hexanoic acid
1H-Pyrazole-5-carboxamide, N-[2-fluoro-5-[[3-[(E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-1,4-dimethyl-
6-(benzenesulfonyl-methyl-amino)-hexanoic acid
6-(Methyl(phenylsulphonyl)amino)hexanoic acid
6-(Benzolsulfonyl-methyl-amino)-hexansaeure

Biological Activity

[Description]:

AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD)[1].

[Related Catalog]:

Research Areas >> Cardiovascular Disease
Signaling Pathways >> Protein Tyrosine Kinase/RTK >> VEGFR

[Target]

VEGFR


[References]

[1]. M.B. Kosa, et al. Ocular and Systemic Pharmacokinetics of AG-013958 With Sub-Tenon Administration To Cynomologus Monkeys. Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5379.

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
648.4±55.0 °C at 760 mmHg

[ Molecular Formula ]:
C26H22FN7O

[ Molecular Weight ]:
467.498

[ Flash Point ]:
345.9±31.5 °C

[ Exact Mass ]:
467.186981

[ PSA ]:
100.52000

[ LogP ]:
3.35

[ Vapour Pressure ]:
0.0±1.9 mmHg at 25°C

[ Index of Refraction ]:
1.691

Related Compounds